Month: September 2020

DENKA press release: Phase I Clinical Study to Develop a Norovirus Vaccine Commenced in Belgium

Posted by

Sep­tem­ber　23, 2020 Den­ka Com­pa­ny Lim­it­ed Den­ka Com­pa­ny Lim­it­ed (head­quar­ters: Chuo-ku, Tokyo; pres­i­dent: Man­abu Yamamo­to; here­inafter, “Den­ka”) announces that Icon Genet­ics GmbH (head­quar­ters: Halle, Sach­sen-Anhalt, Ger­many; CEO: Kazuyu­ki Hiru­ta, here­inafter, ”Icon Genet­ics”, web­site: www.icongenetics.com ), a group com­pa­ny of Den­ka, began a Phase I study for clin­i­cal devel­op­ment of a norovirus vac­cine in Bel­gium.   The… Read more »